US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LMP Capital and Income Fund Inc

14.95

-0.0100-0.07%

Volume:37.32K

Turnover:558.33K

Market Cap:341.72M

PE:2.94

High:15.02

Open:14.95

Low:14.94

Close:14.96

52wk High:16.89

52wk Low:13.79

Shares:22.86M

Float Shares:22.86M

Volume Ratio:0.33

T/O Rate:0.16%

Dividend:1.44

Dividend Rate:9.63%

EPS(TTM):5.09

EPS(LYR):-0.0358

ROE:-0.24%

ROA:1.12%

PB:0.90

PE(LYR):-417.53

Loading ...

Overview Company News Filings

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026

Press Release: Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

LMP Capital and Income Fund updates portfolio management team effective May 1, 2026

LMP Capital and Income Fund files Form 3 for CCO-subadviser Kim Stout

LMP Capital & Income Fund files Form 3 for John Haller, Dir./COO-Subadviser

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine

Press Release: Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

Press Release: Emmaus Life Sciences Reports Annual Financial Results

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease

Press Release: SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

LMP Capital and Income Fund Inc. Announces Annual Stockholders Meeting

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

Novacyt launches rights issue to fund SCD deal and bolster balance sheet

Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Press Release: Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SCD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","market":"US","secType":"STK","nameCN":"LMP Capital and Income Fund Inc","latestPrice":14.95,"timestamp":1777406400000,"preClose":14.96,"halted":0,"volume":37318,"delay":0,"changeRate":-0.000668449197861067,"floatShares":22857660,"shares":22857660,"eps":5.09,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"04-29 06:07:39 EDT","open":14.95,"high":15.02,"low":14.94,"amount":558326.55275,"amplitude":0.005348,"askPrice":16.92,"askSize":100,"bidPrice":14.4,"bidSize":150,"shortable":3,"etf":0,"ttmEps":5.09,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777469400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":14.95,"dividendRate":0.096301,"postHourTrading":{"tag":"盘后","latestPrice":14.97,"preClose":14.95,"latestTime":"16:10 EDT","volume":8,"amount":119.6,"timestamp":1777407004558,"change":0.02,"changeRate":0.001338,"amplitude":0},"volumeRatio":0.3335153394066118},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","floatShares":22857660,"roa":"1.12%","roe":"-0.24%","lyrEps":-0.035806,"volumeRatio":0.3335153394066118,"shares":22857660,"dividePrice":1.4397,"high":15.02,"amplitude":0.005348,"preClose":14.96,"low":14.94,"week52Low":13.79,"pbRate":"0.90","psRate":"29.29","week52High":16.89,"institutionHeld":0.4274,"latestPrice":14.95,"committee":0.2,"eps":5.09,"divideRate":0.096301,"volume":37318,"delay":0,"ttmEps":5.09,"open":14.95,"prevYearClose":14.81,"prevWeekClose":15.07,"prevMonthClose":14.93,"prevQuarterClose":14.93,"fiveDayClose":15.19,"twentyDayClose":14.65,"sixtyDayClose":15.59,"dividendPayoutRate":0.26655632230905396,"dividendFrequency":"M","dividendGrowthYears":2,"dividendGrowthRate":0.04646017699115057,"fiveYearAvgDividendRate":0.12474605069697212},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCD\",params:#limit:5,,,undefined,":[{"date":"2026-05-21","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-21","defaultRemindTime":1779370200000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-21","currency":"USD","dateTimestamp":1779336000000,"payDate":"2026-05-29"},{"date":"2026-04-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-23","defaultRemindTime":1776951000000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-23","currency":"USD","dateTimestamp":1776916800000,"payDate":"2026-04-30"},{"date":"2026-03-24","symbol":"SCD","amount":0.12,"announcedDate":"2026-02-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2026-02-20","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-02-27"},{"date":"2026-01-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-23","defaultRemindTime":1769178600000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-30","payableDate":"2026-01-23","currency":"USD","dateTimestamp":1769144400000,"payDate":"2026-01-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCD\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-15","recordDate":"2016-06-17","paymentDate":"2016-06-24","value":0.31,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.31,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.31,"currency":"USD"},{"executeDate":"2017-03-22","recordDate":"2017-03-24","paymentDate":"2017-04-03","value":0.31,"currency":"USD"},{"executeDate":"2017-06-21","recordDate":"2017-06-23","paymentDate":"2017-07-03","value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCD","date":"2026-04-27","current":2.937132,"percent":0.035362,"low":-448.456166,"twenty":-22.086281,"median":2.898652,"eighty":4.797477,"high":18.396706,"avg":-26.481597,"sd":95.57879,"marketCap":345198483},"quantilePoints":[{"date":"2021-04-30","current":-10.794712,"twenty":-5.459966,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-07","current":-10.931252,"twenty":-5.477043,"median":8.507985,"eighty":90.097979,"marketCap":244456055},{"date":"2021-05-14","current":-10.794712,"twenty":-5.499813,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-21","current":-11.027634,"twenty":-5.52177,"median":8.507985,"eighty":90.097979,"marketCap":246611436},{"date":"2021-05-28","current":-11.308746,"twenty":-5.539661,"median":8.507985,"eighty":90.097979,"marketCap":252897962},{"date":"2021-06-04","current":-11.549699,"twenty":-5.555112,"median":8.507985,"eighty":90.097979,"marketCap":258286413},{"date":"2021-06-11","current":-11.935225,"twenty":-5.57463,"median":8.507985,"eighty":90.097979,"marketCap":266907934},{"date":"2021-06-18","current":-11.493477,"twenty":-5.582762,"median":8.507985,"eighty":90.097979,"marketCap":257029107},{"date":"2021-06-25","current":-11.477413,"twenty":-5.590894,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-07-02","current":-11.738446,"twenty":-5.608785,"median":8.507985,"eighty":90.097979,"marketCap":262507366},{"date":"2021-07-09","current":-11.68624,"twenty":-5.619357,"median":8.507985,"eighty":90.097979,"marketCap":261339868},{"date":"2021-07-16","current":-11.405127,"twenty":-5.629115,"median":8.507985,"eighty":90.097979,"marketCap":255053342},{"date":"2021-07-23","current":-11.501509,"twenty":-5.673826,"median":8.507985,"eighty":90.097979,"marketCap":257208722},{"date":"2021-07-30","current":2.940516,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256131032},{"date":"2021-08-06","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-08-13","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-08-20","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-08-27","current":3.008565,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":262058328},{"date":"2021-09-03","current":3.045682,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":265291399},{"date":"2021-09-10","current":2.997966,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261135107},{"date":"2021-09-17","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-09-24","current":2.86422,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":249485276},{"date":"2021-10-01","current":2.855971,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":248766816},{"date":"2021-10-08","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-10-15","current":2.963199,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":258106798},{"date":"2021-10-22","current":3.035372,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264393324},{"date":"2021-10-29","current":3.039496,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264752554},{"date":"2021-11-05","current":3.066303,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":267087549},{"date":"2021-11-12","current":3.082799,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":268524469},{"date":"2021-11-19","current":3.041558,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264932169},{"date":"2021-11-26","current":2.98382,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259902948},{"date":"2021-12-03","current":2.897213,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252359117},{"date":"2021-12-10","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-12-17","current":2.981758,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259723333},{"date":"2021-12-23","current":3.004441,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261699098},{"date":"2021-12-31","current":3.134351,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":273014845},{"date":"2022-01-07","current":3.084862,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":268704084},{"date":"2022-01-14","current":3.047744,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":265471014},{"date":"2022-01-21","current":2.876592,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":250562966},{"date":"2022-01-28","current":2.907523,"twenty":-9.236022,"median":8.45586,"eighty":89.994993,"marketCap":253257192},{"date":"2022-02-04","current":3.014751,"twenty":-9.236022,"median":8.432693,"eighty":89.994993,"marketCap":262597173},{"date":"2022-02-11","current":2.942579,"twenty":-9.236022,"median":8.412422,"eighty":89.994993,"marketCap":256310647},{"date":"2022-02-18","current":2.921958,"twenty":-9.236022,"median":8.392152,"eighty":89.994993,"marketCap":254514497},{"date":"2022-02-25","current":2.913709,"twenty":-9.236022,"median":8.374777,"eighty":89.994993,"marketCap":253796037},{"date":"2022-03-04","current":2.882049,"twenty":-9.236022,"median":8.366089,"eighty":89.994993,"marketCap":251038288},{"date":"2022-03-11","current":2.817511,"twenty":-9.236022,"median":8.345818,"eighty":89.994993,"marketCap":245416717},{"date":"2022-03-18","current":2.914318,"twenty":-9.236022,"median":8.325547,"eighty":89.994993,"marketCap":253849074},{"date":"2022-03-25","current":2.884066,"twenty":-9.236022,"median":8.30238,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-01","current":2.972806,"twenty":-9.236022,"median":8.287901,"eighty":89.994993,"marketCap":258943623},{"date":"2022-04-08","current":2.884066,"twenty":-9.236022,"median":8.270526,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-14","current":2.851797,"twenty":-9.236022,"median":8.235776,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-22","current":2.851797,"twenty":-9.236022,"median":8.209598,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-29","current":2.682383,"twenty":-9.236022,"median":8.189443,"eighty":89.994993,"marketCap":233646553},{"date":"2022-05-06","current":2.734821,"twenty":-9.236022,"median":8.180755,"eighty":89.994993,"marketCap":238214079},{"date":"2022-05-13","current":2.625912,"twenty":-9.236022,"median":8.166276,"eighty":89.994993,"marketCap":228727678},{"date":"2022-05-20","current":2.60776,"twenty":-9.236022,"median":8.151797,"eighty":89.994993,"marketCap":227146611},{"date":"2022-05-27","current":2.797342,"twenty":-9.236022,"median":8.105463,"eighty":89.994993,"marketCap":243659976},{"date":"2022-06-03","current":2.823561,"twenty":-9.236022,"median":8.073609,"eighty":89.994993,"marketCap":245943740},{"date":"2022-06-10","current":2.732804,"twenty":-9.236022,"median":8.053338,"eighty":89.994993,"marketCap":238038405},{"date":"2022-06-17","current":2.404061,"twenty":-9.236022,"median":8.021484,"eighty":89.994993,"marketCap":209403527},{"date":"2022-06-24","current":2.500868,"twenty":-9.247434,"median":8.004109,"eighty":90.097979,"marketCap":217835884},{"date":"2022-07-01","current":2.517003,"twenty":-9.247434,"median":7.980942,"eighty":90.097979,"marketCap":219241276},{"date":"2022-07-08","current":2.537171,"twenty":-9.247434,"median":7.969359,"eighty":90.097979,"marketCap":220998017},{"date":"2022-07-15","current":2.535154,"twenty":-9.247434,"median":7.957775,"eighty":90.097979,"marketCap":220822343},{"date":"2022-07-22","current":2.595659,"twenty":-9.247434,"median":7.934609,"eighty":90.097979,"marketCap":226092566},{"date":"2022-07-29","current":2.704568,"twenty":-9.247434,"median":6.088551,"eighty":90.097979,"marketCap":235578968},{"date":"2022-08-05","current":2.688433,"twenty":-9.247434,"median":6.007831,"eighty":90.097979,"marketCap":234173575},{"date":"2022-08-12","current":2.785241,"twenty":-9.247434,"median":5.973237,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-19","current":2.785241,"twenty":-9.247434,"median":5.900205,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-26","current":2.696501,"twenty":-9.247434,"median":5.312107,"eighty":90.097979,"marketCap":234876271},{"date":"2022-09-02","current":2.573474,"twenty":-9.247434,"median":4.989229,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-09","current":2.654147,"twenty":-9.247434,"median":4.262754,"eighty":90.097979,"marketCap":231187115},{"date":"2022-09-16","current":2.573474,"twenty":-9.247434,"median":4.089784,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-23","current":2.31532,"twenty":-9.247434,"median":4.043659,"eighty":90.097979,"marketCap":201673866},{"date":"2022-09-30","current":2.272967,"twenty":-9.247434,"median":3.99369,"eighty":90.097979,"marketCap":197984710},{"date":"2022-10-07","current":2.291118,"twenty":-9.247434,"median":3.951408,"eighty":90.097979,"marketCap":199565777},{"date":"2022-10-14","current":2.268933,"twenty":-9.247434,"median":3.905283,"eighty":90.097979,"marketCap":197633362},{"date":"2022-10-21","current":2.333472,"twenty":-9.247434,"median":3.889907,"eighty":90.097979,"marketCap":203254933},{"date":"2022-10-28","current":2.450448,"twenty":-9.247434,"median":3.870689,"eighty":90.097979,"marketCap":213444031},{"date":"2022-11-04","current":2.429271,"twenty":-9.247434,"median":3.839938,"eighty":90.097979,"marketCap":211599453},{"date":"2022-11-11","current":2.581542,"twenty":-9.247434,"median":3.813032,"eighty":90.097979,"marketCap":224862848},{"date":"2022-11-18","current":2.559356,"twenty":-9.247434,"median":3.751531,"eighty":90.097979,"marketCap":222930432},{"date":"2022-11-25","current":2.597676,"twenty":-9.247434,"median":3.716937,"eighty":90.097979,"marketCap":226268240},{"date":"2022-12-02","current":2.585575,"twenty":-9.247434,"median":3.663124,"eighty":90.097979,"marketCap":225214196},{"date":"2022-12-09","current":2.4807,"twenty":-9.247434,"median":3.58671,"eighty":90.097979,"marketCap":216079143},{"date":"2022-12-16","current":2.460532,"twenty":-9.247434,"median":3.555498,"eighty":90.097979,"marketCap":214322402},{"date":"2022-12-23","current":2.381875,"twenty":-9.247434,"median":3.490154,"eighty":90.097979,"marketCap":207471112},{"date":"2022-12-30","current":2.428263,"twenty":-9.247434,"median":3.309496,"eighty":90.097979,"marketCap":211511616},{"date":"2023-01-06","current":2.420195,"twenty":-9.247434,"median":3.134351,"eighty":90.097979,"marketCap":210808920},{"date":"2023-01-13","current":2.537171,"twenty":-9.247434,"median":3.098088,"eighty":90.097979,"marketCap":220998017},{"date":"2023-01-20","current":2.484734,"twenty":-9.247434,"median":3.084862,"eighty":90.097979,"marketCap":216430491},{"date":"2023-01-27","current":2.535154,"twenty":-9.247434,"median":3.080737,"eighty":90.097979,"marketCap":220822343},{"date":"2023-02-03","current":-73.781452,"twenty":-9.441436,"median":3.070427,"eighty":90.097979,"marketCap":223633129},{"date":"2023-02-10","current":-73.607575,"twenty":-9.615782,"median":3.064241,"eighty":90.097979,"marketCap":223106107},{"date":"2023-02-17","current":-73.549616,"twenty":-9.666828,"median":3.055993,"eighty":90.097979,"marketCap":222930432},{"date":"2023-02-24","current":-71.289227,"twenty":-9.690595,"median":3.049806,"eighty":90.097979,"marketCap":216079143},{"date":"2023-03-03","current":-72.738194,"twenty":-9.745753,"median":3.04362,"eighty":90.097979,"marketCap":220470995},{"date":"2023-03-10","current":-69.376589,"twenty":-9.806616,"median":3.039496,"eighty":90.097979,"marketCap":210281897},{"date":"2023-03-17","current":-67.695786,"twenty":-9.852264,"median":3.025061,"eighty":90.097979,"marketCap":205187348},{"date":"2023-03-24","current":-66.826405,"twenty":-9.868605,"median":3.014751,"eighty":90.097979,"marketCap":202552237},{"date":"2023-03-31","current":-70.767598,"twenty":-9.889524,"median":3.009081,"eighty":89.994993,"marketCap":214498076},{"date":"2023-04-06","current":-69.666382,"twenty":-9.905569,"median":3.008565,"eighty":90.30395,"marketCap":211160268},{"date":"2023-04-19","current":-72.622277,"twenty":-9.923821,"median":3.000317,"eighty":90.612908,"marketCap":220119647},{"date":"2023-04-28","current":-70.477804,"twenty":-9.947385,"median":2.994306,"eighty":90.81888,"marketCap":213619705},{"date":"2023-05-05","current":-68.507208,"twenty":-9.985022,"median":2.990006,"eighty":90.81888,"marketCap":207646786},{"date":"2023-05-12","current":-69.724341,"twenty":-9.994912,"median":2.985882,"eighty":90.81888,"marketCap":211335942},{"date":"2023-05-19","current":-70.65168,"twenty":-10.046106,"median":2.981758,"eighty":90.81888,"marketCap":214146727},{"date":"2023-05-26","current":-69.492506,"twenty":-10.086379,"median":2.97351,"eighty":90.81888,"marketCap":210633245},{"date":"2023-06-02","current":-69.898217,"twenty":-10.114737,"median":2.967323,"eighty":90.81888,"marketCap":211862964},{"date":"2023-06-09","current":-71.984731,"twenty":-10.155699,"median":2.961137,"eighty":90.81888,"marketCap":218187232},{"date":"2023-06-16","current":-73.72813,"twenty":-10.198754,"median":2.952889,"eighty":90.81888,"marketCap":223471509},{"date":"2023-06-23","current":-72.04269,"twenty":-10.25168,"median":2.947653,"eighty":90.921866,"marketCap":218362906},{"date":"2023-06-30","current":-72.680236,"twenty":-10.270699,"median":2.944641,"eighty":90.951291,"marketCap":220295321},{"date":"2023-07-07","current":-71.694937,"twenty":-10.28097,"median":2.940516,"eighty":90.951291,"marketCap":217308861},{"date":"2023-07-14","current":-73.897369,"twenty":-10.318249,"median":2.932268,"eighty":90.951291,"marketCap":223984477},{"date":"2023-07-20","current":-74.882667,"twenty":-10.336901,"median":2.919896,"eighty":90.951291,"marketCap":226970937},{"date":"2023-07-28","current":-73.955328,"twenty":-10.373407,"median":2.915045,"eighty":90.097979,"marketCap":224160151},{"date":"2023-08-04","current":-21.900189,"twenty":-10.41739,"median":2.903399,"eighty":16.981542,"marketCap":223281781},{"date":"2023-08-11","current":-22.055265,"twenty":-10.473441,"median":2.901337,"eighty":16.844419,"marketCap":224862848},{"date":"2023-08-18","current":-22.072496,"twenty":-10.502916,"median":2.898184,"eighty":16.694236,"marketCap":225038522},{"date":"2023-08-25","current":-22.313725,"twenty":-10.566513,"median":2.891027,"eighty":16.544053,"marketCap":227497959},{"date":"2023-09-01","current":-22.882338,"twenty":-10.63247,"median":2.882837,"eighty":16.443931,"marketCap":233295204},{"date":"2023-09-08","current":-22.67557,"twenty":-10.683175,"median":2.880716,"eighty":16.319867,"marketCap":231187115},{"date":"2023-09-15","current":-22.244803,"twenty":-10.736884,"median":2.86422,"eighty":15.971617,"marketCap":226795263},{"date":"2023-09-22","current":-21.641729,"twenty":-10.809272,"median":2.8559,"eighty":15.823611,"marketCap":220646669},{"date":"2023-09-29","current":-21.15927,"twenty":-10.841294,"median":2.84978,"eighty":15.76702,"marketCap":215727794},{"date":"2023-10-06","current":-20.556197,"twenty":-10.858966,"median":2.844673,"eighty":15.730018,"marketCap":209579201},{"date":"2023-10-13","current":-21.176501,"twenty":-10.942973,"median":2.837413,"eighty":15.682134,"marketCap":215903468},{"date":"2023-10-20","current":-21.538345,"twenty":-11.00106,"median":2.831227,"eighty":15.636426,"marketCap":219592625},{"date":"2023-10-27","current":-19.901431,"twenty":-11.016276,"median":2.825578,"eighty":15.595072,"marketCap":202903585},{"date":"2023-11-03","current":-21.004194,"twenty":-11.082846,"median":2.817511,"eighty":15.534128,"marketCap":214146727},{"date":"2023-11-10","current":-20.590658,"twenty":-11.117081,"median":2.795325,"eighty":15.431829,"marketCap":209930549},{"date":"2023-11-17","current":-21.831267,"twenty":-11.164174,"median":2.785241,"eighty":15.34912,"marketCap":222579084},{"date":"2023-11-24","current":-22.244803,"twenty":-11.204054,"median":2.762048,"eighty":15.281647,"marketCap":226795263},{"date":"2023-12-01","current":-22.67557,"twenty":-11.254024,"median":2.732804,"eighty":15.148876,"marketCap":231187115},{"date":"2023-12-08","current":-22.589416,"twenty":-11.310355,"median":2.726754,"eighty":15.090109,"marketCap":230308745},{"date":"2023-12-15","current":-23.347566,"twenty":-11.356937,"median":2.704568,"eighty":15.022635,"marketCap":238038405},{"date":"2023-12-22","current":-23.881717,"twenty":-11.397096,"median":2.696501,"eighty":14.979104,"marketCap":243484302},{"date":"2023-12-29","current":-24.191869,"twenty":-11.411888,"median":2.69045,"eighty":14.913807,"marketCap":246646436},{"date":"2024-01-05","current":-23.881717,"twenty":-11.451962,"median":2.683391,"eighty":14.85504,"marketCap":243484302},{"date":"2024-01-12","current":-23.674949,"twenty":-11.477413,"median":2.65919,"eighty":14.800626,"marketCap":241376213},{"date":"2024-01-19","current":-23.45095,"twenty":-11.499903,"median":2.642046,"eighty":14.713563,"marketCap":239092450},{"date":"2024-01-26","current":-23.778333,"twenty":-11.543274,"median":2.622886,"eighty":14.58297,"marketCap":242430258},{"date":"2024-02-02","current":9.626529,"twenty":-11.568976,"median":2.616836,"eighty":14.349599,"marketCap":243659976},{"date":"2024-02-09","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-02-16","current":9.834745,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":248930199},{"date":"2024-02-23","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-03-01","current":9.786162,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":247700481},{"date":"2024-03-08","current":9.756733,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":246955611},{"date":"2024-03-15","current":10.007253,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":253296595},{"date":"2024-03-22","current":10.183294,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":257752421},{"date":"2024-03-28","current":10.460897,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264778917},{"date":"2024-04-05","current":10.257773,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":259637579},{"date":"2024-04-12","current":10.176523,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":257581043},{"date":"2024-04-19","current":9.763504,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":247126989},{"date":"2024-04-26","current":10.14944,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":256895532},{"date":"2024-05-03","current":10.227304,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258866378},{"date":"2024-05-10","current":10.413502,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263579271},{"date":"2024-05-17","current":10.447356,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264436161},{"date":"2024-05-24","current":10.217148,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258609311},{"date":"2024-05-31","current":10.095274,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":255524508},{"date":"2024-06-07","current":10.406731,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263407893},{"date":"2024-06-14","current":10.460897,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":264778917},{"date":"2024-06-21","current":10.359335,"twenty":-11.575401,"median":2.613811,"eighty":9.637634,"marketCap":262208248},{"date":"2024-06-28","current":10.403684,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":263330773},{"date":"2024-07-05","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-07-12","current":10.494751,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":265635807},{"date":"2024-07-15","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-08-02","current":4.208455,"twenty":-11.59789,"median":2.60171,"eighty":5.980925,"marketCap":267178208},{"date":"2024-08-09","current":4.170663,"twenty":-11.59789,"median":2.60171,"eighty":5.938643,"marketCap":264778917},{"date":"2024-08-16","current":4.265144,"twenty":-11.59789,"median":2.60171,"eighty":5.362076,"marketCap":270777145},{"date":"2024-08-23","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":5.046886,"marketCap":280717065},{"date":"2024-08-30","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":4.421713,"marketCap":280717065},{"date":"2024-09-06","current":4.419013,"twenty":-11.59789,"median":2.60171,"eighty":4.408215,"marketCap":280545687},{"date":"2024-09-13","current":4.451407,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":282602223},{"date":"2024-09-20","current":4.753746,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":301796552},{"date":"2024-09-27","current":4.699757,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":298368993},{"date":"2024-10-04","current":4.815833,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":305738244},{"date":"2024-10-11","current":4.664664,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":296141080},{"date":"2024-10-18","current":4.688959,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":297683481},{"date":"2024-10-25","current":4.591778,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":291513875},{"date":"2024-10-31","current":4.53509,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":287914939},{"date":"2024-11-08","current":4.613374,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292884899},{"date":"2024-11-15","current":4.599877,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292028009},{"date":"2024-11-22","current":4.670063,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296483836},{"date":"2024-11-29","current":4.813134,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":305566867},{"date":"2024-12-06","current":4.756445,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":301967930},{"date":"2024-12-13","current":4.678161,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296997970},{"date":"2024-12-20","current":4.443308,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":282088089},{"date":"2024-12-27","current":4.645768,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":294941434},{"date":"2025-01-03","current":4.605276,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292370765},{"date":"2025-01-10","current":4.526991,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":287400805},{"date":"2025-01-17","current":4.605276,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":292370765},{"date":"2025-01-24","current":4.769943,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":302824819},{"date":"2025-01-31","current":3.372162,"twenty":-11.610741,"median":2.597676,"eighty":4.349907,"marketCap":294084545},{"date":"2025-02-07","current":3.368232,"twenty":-11.610741,"median":2.597676,"eighty":4.270338,"marketCap":293741789},{"date":"2025-02-14","current":3.374127,"twenty":-11.610741,"median":2.597676,"eighty":4.219659,"marketCap":294255922},{"date":"2025-02-21","current":3.415395,"twenty":-11.610741,"median":2.597676,"eighty":4.178221,"marketCap":297854859},{"date":"2025-02-28","current":3.295129,"twenty":-11.610741,"median":2.597676,"eighty":4.101017,"marketCap":287366529},{"date":"2025-03-07","current":3.155998,"twenty":-11.617166,"median":2.597676,"eighty":4.050578,"marketCap":275232971},{"date":"2025-03-14","current":3.072474,"twenty":-11.617166,"median":2.597676,"eighty":4.019762,"marketCap":267948919},{"date":"2025-03-21","current":3.19042,"twenty":-11.617166,"median":2.602718,"eighty":4.019762,"marketCap":278234866},{"date":"2025-03-28","current":3.143241,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":274120487},{"date":"2025-04-04","current":3.008068,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":262332100},{"date":"2025-04-11","current":2.734909,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":238510000},{"date":"2025-04-17","current":2.844071,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":248030000},{"date":"2025-04-25","current":2.941538,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":256530000},{"date":"2025-05-02","current":2.982474,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":260100000},{"date":"2025-05-09","current":2.966879,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":258740000},{"date":"2025-05-16","current":3.07994,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":268600000},{"date":"2025-05-23","current":3.048751,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":265880000},{"date":"2025-05-30","current":3.081889,"twenty":-11.617166,"median":2.604735,"eighty":4.005123,"marketCap":268770000},{"date":"2025-06-06","current":3.280721,"twenty":-11.617166,"median":2.604735,"eighty":3.951408,"marketCap":286110000},{"date":"2025-06-13","current":3.035105,"twenty":-11.617166,"median":2.604735,"eighty":3.905283,"marketCap":264690000},{"date":"2025-06-20","current":3.084001,"twenty":-11.623592,"median":2.603727,"eighty":3.88837,"marketCap":268954204},{"date":"2025-06-27","current":3.062339,"twenty":-11.623592,"median":2.603727,"eighty":3.873763,"marketCap":267064998},{"date":"2025-07-03","current":3.145051,"twenty":-11.623592,"median":2.603727,"eighty":3.866076,"marketCap":274278330},{"date":"2025-07-11","current":3.085971,"twenty":-11.623592,"median":2.603727,"eighty":3.415002,"marketCap":269125950},{"date":"2025-07-18","current":3.036737,"twenty":-11.623592,"median":2.603727,"eighty":3.373734,"marketCap":264832301},{"date":"2025-07-25","current":2.99735,"twenty":-11.623592,"median":2.603727,"eighty":3.366267,"marketCap":261397381},{"date":"2025-08-01","current":17.519573,"twenty":-11.623592,"median":2.60776,"eighty":3.371376,"marketCap":347455217},{"date":"2025-08-08","current":17.473408,"twenty":-11.623592,"median":2.625912,"eighty":3.411858,"marketCap":346539656},{"date":"2025-08-15","current":17.611903,"twenty":-11.623592,"median":2.64524,"eighty":4.08345,"marketCap":349286338},{"date":"2025-08-22","current":17.646527,"twenty":-11.623592,"median":2.672299,"eighty":4.191719,"marketCap":349973008},{"date":"2025-08-29","current":17.900433,"twenty":-11.623592,"median":2.688433,"eighty":4.310495,"marketCap":355008591},{"date":"2025-09-05","current":17.831186,"twenty":-11.630017,"median":2.696501,"eighty":4.359625,"marketCap":353635250},{"date":"2025-09-12","current":18.038928,"twenty":-11.623592,"median":2.704568,"eighty":4.407135,"marketCap":357755273},{"date":"2025-09-19","current":18.258211,"twenty":-11.623592,"median":2.72272,"eighty":4.421173,"marketCap":362104185},{"date":"2025-09-26","current":17.946598,"twenty":-11.623592,"median":2.732804,"eighty":4.449787,"marketCap":355924152},{"date":"2025-10-03","current":17.877351,"twenty":-11.623592,"median":2.748938,"eighty":4.510795,"marketCap":354550811},{"date":"2025-10-10","current":18.073552,"twenty":-11.623592,"median":2.781208,"eighty":4.53347,"marketCap":358441943},{"date":"2025-10-17","current":17.369537,"twenty":-11.623592,"median":2.785241,"eighty":4.568563,"marketCap":344479645},{"date":"2025-10-24","current":17.381078,"twenty":-11.623592,"median":2.797342,"eighty":4.593938,"marketCap":344708535},{"date":"2025-10-31","current":17.20796,"twenty":-11.623592,"median":2.817511,"eighty":4.605276,"marketCap":341275183},{"date":"2025-11-07","current":17.011759,"twenty":-11.623592,"median":2.82504,"eighty":4.612294,"marketCap":337384051},{"date":"2025-11-14","current":16.942512,"twenty":-11.623592,"median":2.831227,"eighty":4.641448,"marketCap":336010710},{"date":"2025-11-21","current":16.100003,"twenty":-11.623592,"median":2.837413,"eighty":4.661403,"marketCap":319301731},{"date":"2025-11-28","current":16.907888,"twenty":-11.623592,"median":2.839475,"eighty":4.672222,"marketCap":335324040},{"date":"2025-12-05","current":17.219501,"twenty":-11.623592,"median":2.845746,"eighty":4.68302,"marketCap":341504073},{"date":"2025-12-12","current":17.011759,"twenty":-11.623592,"median":2.851868,"eighty":4.693818,"marketCap":337384051},{"date":"2025-12-19","current":16.861724,"twenty":-11.623592,"median":2.857847,"eighty":4.704616,"marketCap":334408479},{"date":"2025-12-26","current":17.173336,"twenty":-11.623592,"median":2.86422,"eighty":4.718653,"marketCap":340588513},{"date":"2026-01-02","current":17.092548,"twenty":-11.623592,"median":2.876592,"eighty":4.726211,"marketCap":338986282},{"date":"2026-01-09","current":17.484949,"twenty":-11.623592,"median":2.884066,"eighty":4.741868,"marketCap":346768546},{"date":"2026-01-16","current":17.750398,"twenty":-11.623592,"median":2.892133,"eighty":4.755905,"marketCap":352033019},{"date":"2026-01-23","current":17.854269,"twenty":-11.623592,"median":2.898184,"eighty":4.785059,"marketCap":354093031},{"date":"2026-01-30","current":-433.386699,"twenty":-11.673389,"median":2.898652,"eighty":4.797477,"marketCap":355466371},{"date":"2026-02-06","current":-434.782021,"twenty":-11.806716,"median":2.898652,"eighty":4.797477,"marketCap":356610822},{"date":"2026-02-13","current":-443.991139,"twenty":-11.89346,"median":2.898652,"eighty":4.797477,"marketCap":364164196},{"date":"2026-02-20","current":-445.665524,"twenty":-19.997923,"median":2.898652,"eighty":4.797477,"marketCap":365537537},{"date":"2026-02-27","current":-444.270203,"twenty":-20.645796,"median":2.898652,"eighty":4.797477,"marketCap":364393086},{"date":"2026-03-06","current":-436.73547,"twenty":-21.000748,"median":2.898652,"eighty":4.797477,"marketCap":358213053},{"date":"2026-03-13","current":-420.828811,"twenty":-21.104132,"median":2.898652,"eighty":4.797477,"marketCap":345166316},{"date":"2026-03-20","current":-417.796,"twenty":-21.217855,"median":2.898652,"eighty":4.797477,"marketCap":342678786},{"date":"2026-03-27","current":-415.003246,"twenty":-21.297116,"median":2.898652,"eighty":4.797477,"marketCap":340388152},{"date":"2026-04-02","current":-418.354551,"twenty":-21.538345,"median":2.898652,"eighty":4.797477,"marketCap":343136913},{"date":"2026-04-10","current":-424.777885,"twenty":-21.796633,"median":2.898652,"eighty":4.797477,"marketCap":348405370},{"date":"2026-04-17","current":-428.687741,"twenty":-21.965666,"median":2.898652,"eighty":4.797477,"marketCap":351612257},{"date":"2026-04-24","current":-420.868029,"twenty":-22.06905,"median":2.898652,"eighty":4.797477,"marketCap":345198483},{"date":"2026-04-27","current":-420.868029,"twenty":-22.086281,"median":2.898652,"eighty":4.797477,"marketCap":345198483}],"updateTime":1777451332889},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630393340","title":"Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393340","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393340?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287600,"startTime":"0","endTime":"0","summary":"― Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of hemolysis and anemia, and encouraging trends in vaso-occlu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281455/0/en/Fulcrum-Therapeutics-Announces-Recent-Business-Highlights-and-Financial-Results-for-First-Quarter-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FULC","BK4213","SCD","VOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630398398","title":"Press Release: Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2630398398","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630398398?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:55","pubTimestamp":1777287300,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April 27, 2026  -- Fulcrum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing small molecules that improve the lives of patients with rare hematological disorders, today announced that Josh Lehrer, M.D., M.Phil., FACC, has been appointed to its Board of Directors as an independent director.\"We are delighted to welcome Josh to Fulcrum's Board of Directors,\" said Alex C. Sapir, President and Chief Executive Officer of Fulcrum Therapeutics. \"Josh brings deep expertise in rare disease drug development and a strong track record advancing transformative therapies, including his leadership in the development and approval of Oxbryta for patients with sickle cell disease. His experience will be invaluable as we continue advancing pociredir and our broader benign hematology pipeline.\". Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecules that improve the lives of people with rare hematologic","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4022","BK4232","SCD","FULC","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629071294","title":"Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629071294","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629071294?lang=en_us&edition=fundamental","pubTime":"2026-04-23 07:54","pubTimestamp":1776902040,"startTime":"0","endTime":"0","summary":"CHICAGO, April  22, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) today announced that it has entered into a co-development agreement with Adbiotech Co., Ltd. (KOSDAQ: 179530), a Korea-based b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3279497/33289/en/Exicure-Announces-Co-Development-Agreement-with-Adbiotech-for-Burixafor-GPC-100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2237443549.SGD","LU2237443622.USD","LU2237443978.SGD","LU1791710582.SGD","LU2237443382.USD","SCD","LU1791710400.SGD","LU0528227936.USD","BK4585","BK4159","GPC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628483205","title":"LMP Capital and Income Fund updates portfolio management team effective May 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628483205","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628483205?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:01","pubTimestamp":1776427318,"startTime":"0","endTime":"0","summary":"LMP Capital and Income Fund named a new day-to-day portfolio management team effective May 1, 2026.Western Asset appointees: Michael Buchanan, Ryan Brist, Christopher Kilpatrick, Mark Lindbloom, Walter Kilcullen.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL8wTPHg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625968333","title":"LMP Capital and Income Fund files Form 3 for CCO-subadviser Kim Stout","url":"https://stock-news.laohu8.com/highlight/detail?id=2625968333","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625968333?lang=en_us&edition=fundamental","pubTime":"2026-04-08 02:06","pubTimestamp":1775585166,"startTime":"0","endTime":"0","summary":"LMP Capital & Income Fund filed an initial Form 3 naming Kim Stout as CCO and subadviser.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLbc5dNQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624685537","title":"LMP Capital & Income Fund files Form 3 for John Haller, Dir./COO-Subadviser","url":"https://stock-news.laohu8.com/highlight/detail?id=2624685537","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624685537?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:36","pubTimestamp":1775147764,"startTime":"0","endTime":"0","summary":"ClearBridge Investments executive John Haller filed an initial Form 3 for LMP Capital & Income Fund, listing his role as director and COO of the subadviser, effective Jan. 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL3xZr0c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SCD","BEN","BK4135","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624542149","title":"Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2624542149","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624542149?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:12","pubTimestamp":1775077920,"startTime":"0","endTime":"0","summary":"Prestigious Publication Reinforces risto-cel’s Durable, Differentiated Clinical Data for the Treatment of SCD with Severe Vaso-occlusive Crises (VOCs) Initially Presented at ASH, Data from 31 Patients","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/01/3267053/0/en/Beam-Therapeutics-Announces-Publication-of-BEACON-Phase-1-2-Data-for-risto-cel-in-Patients-with-Sickle-Cell-Disease-SCD-in-The-New-England-Journal-of-Medicine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH","HSCT","LU2463526074.USD","BK4139","SCD","BK4539","BK4109","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623759586","title":"Press Release: Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2623759586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623759586?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:00","pubTimestamp":1774958400,"startTime":"0","endTime":"0","summary":"The 19 monthly distribution notices for BrandywineGLOBAL - Global Income Opportunities Fund Inc. , Western Asset Emerging Markets Debt Fund Inc. , LMP Capital and Income Fund Inc. , Western Asset Inflation-Linked Income Fund  and Western Asset Inflation-Linked Opportunities & Income Fund  are now available. These informational notices provide further details on the sources of the funds' monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund's current distribution and its cumulative distributions paid this fiscal year-to-date. Amounts are expressed on a per share of common stock basis, and as a percentage of the distribution amount.Ticker   period    March 2026     Income      gains       gains       Capital","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WIW","FELE","BK4161","LU2229751404.USD","EMD","BWG","WIA","SCD","LU2089279066.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623307846","title":"Press Release: Emmaus Life Sciences Reports Annual Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2623307846","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623307846?lang=en_us&edition=fundamental","pubTime":"2026-03-31 17:32","pubTimestamp":1774949520,"startTime":"0","endTime":"0","summary":"Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2025.\"We experienced a 25% decline in net revenues in 2025 as compared to 2024 due to ongoing competition from generic L-Glutamine in the U.S., partially offset by an increase of sales in the Middle East North Africa, or MENA, region,\" commented Willis Lee, Chairman and Chief Executive Officer of Emmaus. \"We nonetheless realized income from operations of $0.2 million compared to loss from operations of $1.9 million in the prior year due to a 34% reduction in operating expenses. We believe the international markets offer greater growth potential and have undertaken a change in strategy for our U.S. operations going forward by entering into a license and exclusive distribution arrangement with NeoImmuneTech, Inc. which we expect to be fully implemented in ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","R","BK4007","SCD","EMMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623331063","title":"SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623331063","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623331063?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:20","pubTimestamp":1774873200,"startTime":"0","endTime":"0","summary":"Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data In vitro analysis of the SeaStar Medical SCD indicat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264604/0/en/SeaStar-Medical-Showcases-New-Positive-Data-from-the-QUELIMMUNE-SAVE-Registry-and-an-Analysis-of-the-Unique-Immunomodulatory-Mechanism-of-the-SCD-Therapy-at-AKI-CRRT-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4008","BK4500","SAVE","SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622004619","title":"Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004619?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:05","pubTimestamp":1774469100,"startTime":"0","endTime":"0","summary":"Added top-rated children's hospitals to QUELIMMUNE pediatric Acute Kidney Injury  customer base. Completed enrollment in FDA-mandated QUELIMMUNE SAVE Post-Marketing Registry. Exceeded 50% enrollment milestone in pivotal trial of SCD therapy in adult patients with AKI. Advanced pipeline indications with initiation of cardio-renal clinical trial. DENVER, March 25, 2026  -- SeaStar Medical Holding Corporation , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months and year ended December 31, 2025, and provided business updates on key initiatives.\"In 2025, we broadened our customer base of top-ranked children's hospitals, continued enrollment in the NEUTRALIZE-AKI pivotal clinical trial, and advanced our pipeline with the initiation of the cardio-renal clinical trial of our selective cytopheretic device  therapy,\" said Eric Schlorff, CEO of S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","LABU","03160","IE00B66KJ199.SGD","BK4585","BK4099","SCD","ICU","BK4187","IE0031619046.USD","BK4082","BK4588","TM","IE00B7SZL793.SGD","CRS","LU2065731478.USD","BK4006","IE00B19Z4B17.USD","BK4555","LU0963586101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621772207","title":"Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621772207","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621772207?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:00","pubTimestamp":1774263600,"startTime":"0","endTime":"0","summary":"- On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma  by end of this month -. - GLIX1 is positioned to potentially address unmet needs for novel and more effective cancer treatments by targeting DNA damage response mechanisms -. - Management to host conference call today, March 23, at 8:30 am EDT -. TEL AVIV, Israel, March 23, 2026 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2025, and provided a corporate update.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","IE00BYQQ9H92.USD","LU2413666426.HKD","BK4567","LU1721428933.USD","LU1093756325.SGD","BLRX","BK4211","BK4548","BK4121","MTD","BK4109","LU2413666699.HKD","LU2463526074.USD","BK4585","BK4533","ASH","IE00B5TLWC47.USD","IE00BFXG0V08.USD","BK4195","LU1093756168.USD","PFS","SCD","LU2211817866.USD","LU0347712357.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620228529","title":"MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228529","media":"GlobeNewswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228529?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921600,"startTime":"0","endTime":"0","summary":"Three-year collaboration is aimed at enhancing a key aspect of sickle cell management: expediting care during a pain crisisCAMBRIDGE, Mass., March  19, 2026 (GLOBE NEWSWIRE) -- MedicAlert Foundation, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3258908/0/en/MedicAlert-Foundation-Sickle-Cell-Disease-Association-of-America-Inc-SCDAA-and-Fulcrum-Therapeutics-Partner-to-Accelerate-Emergency-Department-Access-to-Critical-Care-Information-f.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4208","LU0170899867.USD","BK4585","ED","LU2346227817.USD","BK4134","FULC","III","SCD","AAQC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620264779","title":"Press Release: SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264779","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264779?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:05","pubTimestamp":1773864300,"startTime":"0","endTime":"0","summary":"DENVER, March 18, 2026  -- SeaStar Medical Holding Corporation , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2025 financial results after market close on Wednesday, March 25, 2026, and host a webcast and conference call to discuss its financial results and business progress.Date/Time:              Wednesday, March 25, 2026, at 4:30 p.m. ET / 2:30. Webcast:                The live webcast and replay can be found here.Register for the call:  Preregistration is required to attend the live call. A replay of the call will be available after 7:30 p.m. ET and can be accessed here.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU","SCD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618674535","title":"LMP Capital and Income Fund Inc. Announces Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2618674535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618674535?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:08","pubTimestamp":1773086937,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL8cvTR3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617540547","title":"SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI","url":"https://stock-news.laohu8.com/highlight/detail?id=2617540547","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617540547?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:20","pubTimestamp":1772716800,"startTime":"0","endTime":"0","summary":"Completion of enrollment marks a key milestone toward satisfying FDA post-approval requirementsDENVER, March  05, 2026  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commerc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/05/3250133/0/en/SeaStar-Medical-Announces-Completion-of-FDA-Enrollment-Requirement-for-SAVE-Surveillance-Registry-Evaluating-QUELIMMUNE-Safety-for-Pediatric-AKI.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4008","BK4500","SCD","SAVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616384818","title":"Novacyt launches rights issue to fund SCD deal and bolster balance sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2616384818","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616384818?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:29","pubTimestamp":1772440140,"startTime":"0","endTime":"0","summary":"Novacyt ( ($FR:ALNOV) ) has shared an update. Novacyt is launching a preferential subscription rights issue to raise up to €784,736 through the iss...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novacyt-launches-rights-issue-to-fund-scd-deal-and-bolster-balance-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novacyt-launches-rights-issue-to-fund-scd-deal-and-bolster-balance-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614865082","title":"Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2614865082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614865082?lang=en_us&edition=fundamental","pubTime":"2026-02-28 01:29","pubTimestamp":1772213340,"startTime":"0","endTime":"0","summary":"-- Strong cash position at year-end 2025: $33.3 million . --    Appointed renowned Rolando Gutierrez-Esteinou, M.D.        --    Seven ongoing oncology trials, with six sponsored by. as new CMO for CNS                                      the NCI or top-tier U.S. institutions. --    Preparing protocol resubmission to incorporate FDA         --    Positive data in 1L AML unfit patients presented at. guidance on Phase III PORTICO-2 trial in aggression                       ASH with 100% ORR . in BPD                               --    Positive data in R/R FLT3+ AML presented at ASH; 67%. into additional EU countries                    --    Initiated enrollment in new Phase Ib trial in small. --    Finalizing preparations for new Phase II trial in                   cell lung cancer in combination with ICI and. aggression in autism spectrum disorder as a part of                                  radiotherapy. the IPCEI EU Grant in personalized medicine             --    Continued momentum ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4081","BK4097","SCD","ET","BK4585","BK4590","BK4109","ASH","HSCT","NCI","BK4202","BK4588","CR","EMA","BK4161","OS","ORR","LU2463526074.USD","BK4561","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614042239","title":"Press Release: Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2614042239","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614042239?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:30","pubTimestamp":1772112600,"startTime":"0","endTime":"0","summary":"-- Pursuing a traditional approval path for bitopertin in erythropoietic. protoporphyria ; Phase 3 APOLLO study is expected to complete. enrollment in March 2026 with topline data expected in Q4 2026. -- Initial data from Phase 2 study of DISC-0974 in patients with anemia of. myelofibrosis  presented at the American Society of Hematology . conference demonstrating meaningful overall anemia responses across all. patient subgroups, regardless of baseline transfusion status or. -- Progressing ongoing Phase 2 study of DISC-3405 in polycythemia vera . and initiated a Phase 1b study of DISC-3405 in sickle cell disease . in Q4 2025, with data from both studies expected in 2H 2026. cash, cash equivalents, and marketable securities, providing runway into. Administration  in February 2026 related to sufficiency of evidence. adolescents with EPP, with topline data expected Q4 2026. anemia of myelofibrosis  presented at ASH Annual Meeting i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4139","LU0053671581.USD","EPP","BK4582","CRL","LU1815336091.USD","LU2463526074.USD","BK4585","BK4121","LU0029874061.USD","LU0757428866.USD","IBD","SCD","BK4530","LU0390134368.USD","BK4588","IE00BFMHRM44.USD","IRON","LU0128526141.USD","ASH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613719554","title":"Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results  for Fourth Quarter and Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719554","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719554?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:01","pubTimestamp":1771934460,"startTime":"0","endTime":"0","summary":"― Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― 20 mg cohort demonstrated rapid and robust fetal hemoglobin ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243387/0/en/Fulcrum-Therapeutics-Announces-Recent-Business-Highlights-and-Financial-Results-for-Fourth-Quarter-and-Full-Year-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOC","LU2463526074.USD","SCD","BK4213","BK4109","BK4007","ASH","FULC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}